Malaysia vs Small island developing States (SIDS): Proportion of the target population who received the final dose of
Malaysia
78.0%
in 2024
Small island developing States (SIDS)
22.0%
in 2024
Malaysia rank
28th
Small island developing States (SIDS) rank
25th
Proportion of the target population who received the final dose of over time
- Malaysia
- Small island developing States (SIDS)
How they compare
Malaysia currently reports 78.0% against 22.0% in Small island developing States (SIDS), a difference of 56.0%.
That makes Malaysia's figure about 3.5 times Small island developing States (SIDS)'s.
The two have swapped places 2 times across 14 shared years of data; in 2011 it was Malaysia ahead.
Malaysia ranks 28th and Small island developing States (SIDS) ranks 25th of 107 countries.
Malaysia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malaysia | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.6% | 4.0% | 78.6% | Malaysia |
| 2020s | 48.2% | 13.2% | 35.0% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Malaysia or Small island developing States (SIDS)?
- Malaysia, at 78.0% against 22.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Malaysia and Small island developing States (SIDS)?
- 56.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Small island developing States (SIDS)?
- 14 years are reported by both, from 2011 to 2024.
- How do Malaysia and Small island developing States (SIDS) rank globally for proportion of the target population who received the final dose of?
- Malaysia ranks 28th and Small island developing States (SIDS) ranks 25th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.